Moderna kept its UK commitment as the science minister admits the UK must pay more for drugs

The price the NHS pays for medicines will need to rise to end the feud with pharmaceutical companies and stop the exodus of investment in the UK, science minister Patrick Vallance has said.

Lord Vallance told the Financial Times that “all options” were on the table in terms of UK drug pricing, after several large pharmaceutical companies had pulled or scrapped investments in recent weeks, citing the UK as uncompetitive.

Critics of the sector credit low prices for new drugs, a lack of government investment and ongoing tariff pressure from Donald Trump to firms turning away from the UK.

Vallance said: “We need to fix the commercial environment so that it’s good enough to get those companies back

See Full Page